Facebook
Linkedin
Pinterest
Reddit
Twitter
HOME
ABOUT
ADVERTISE
EDITORIAL
PRESS RELEASES
CONTACT
MEDICAL DEVICES
BIOTECHNOLOGY
ACQUISITIONS/MERGERS
FUNDING
FDA UPDATES
HOSPITALS
INDUSTRY EXPERT ARTICLES
OTHER NEWS
EXECUTIVES
IMAGING
ULTRASOUND
MARKET REPORTS
NON-PROFIT
HEALTH
ARTICLES
Search
Wednesday, January 15, 2025
LinkedIn
Twitter
Facebook
Instagram
Pinterest
Home
About
Press Releases
Editorial
Advertise
Privacy Statement
MBio Diagnostics
MBio is Seeking FDA Approval for LightDeck® Platform
MBio has been working with DARPA on a program, "Point-of-care Monitoring of the Host-Pathogen Interaction During Infection," since February 2018.
April 6, 2020